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SummARy – The purpose of the study was to retrospectively analyze the prevalence of oral cav-
ity, neck and head tumors recorded at our department over a period of 3 years. Retrospective analysis 
included archival data on cancer patients treated at our department during the 2015-2017 period. A 
total of 1005 patients with proven carcinomas were selected for final analysis. Cancers were detected 
by ultrasound, x-ray, biopsy and clinical diagnosis. The mean age of patients was 58.4±19.3 years. 
The majority of cases (n=264; 26.3%) were detected in the 7th decade of life. The most com-
mon cancers were basal cell carcinoma in 374 (37.2%) and squamous cell carcinoma in 228 
(22.7%) cases. The male-to-female ratio was 1.7:1. There was no statistically significant age 
difference between genders. Recurrence of tumor occurred in 31 patients. The most common 
risk factor in both groups was sun exposure. The most common sites were lower lip, cheek and 
frontal region in men, and cheek region and nose in women (p<0.001). men were found to be more 
susceptible to cancer development. This study showed differences between age groups, i.e. 
el derly patients had a much higher probability of developing cancer as compared to younger 
patients.
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Introduction
Oral cancers are malignant neoplasms that develop 
in the tissues of the mouth1. Oral cancers are the 6th 
most common malignancy worldwide. despite the 
general global trend of a slight decrease in the inci-
dence of oral cancers, the incidence of tongue cancer is 
increasing2. About 90% of all tumors are histologically 
subtyped as oral squamous cell carcinoma (OSCC), 
which is the most common type of oral cancer. Each 
year, about 275,000 cases are newly diagnosed world-
wide, reporting 128,000 deaths annually3. in the Euro-
pean union, there is an estimate of 66,650 new cases 
each year4. At an early stage, OSCC has a survival rate 
of 80% in comparison to late stages (T3-T4) when the 
survival rate is only 20%-30%5. The incidence varies by 
geographic regions, and more than half of all cases oc-
cur in devel oping countries6; however, in the last de-
cade, an increase has been observed in the percentage 
of young patients2.
Early diagnosis of oral cancer is the most impor-
tant factor affecting overall survival and prognosis. 
Several countries in Europe have shown a significant 
increase in the prevalence of oral cancer, especially in 
men. Oral cancer is more common in men and usually 
occurs after the 5th decade of life4. for instance, in Eu-
rope, head and neck cancers are the 4th most common 
group of cancers among men7. france has one of the 
highest incidence rates; in 2012, the world-standard-
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ized incidence for men was 21.5 cases per 100,000 
person-years and in france over 35 cases per 100,000 
person-years for men8,9.
Apart from tobacco and alco hol, dietary factors, 
human papillomavirus (HPv) infection, genetic fac-
tors, and oral hygiene have also been reported as risk 
factors. Social inequalities were related to oral cavity 
cancers, linked to factors directly affecting behavior 
and lifestyle of different genders3,10. Studies have re-
ported an alarming lack of awareness about oral cancer, 
symptoms and early diagnosis. The lack of such knowl-
edge needs to be addressed by further public educa-
tion, and possibly targeted at high-risk groups11. To-
bacco and alcohol consumption are still the principal 
etiologic factors for the develop ment of squamous cell 
carcinoma (SCC). However, in addition, a variety of 
suspected risk factors such as chronic irritation, poor 
oral hygiene, viral infection, occupational exposure, 
nutrition, and genetic factors have been proposed for 
the development of oral cancer12-16.
The aims of this study were to retrospectively ana-
lyze the prevalence of oral cavity, neck and head carci-
noma and evaluate the number of different types of 
cancers encountered at our department over a 3-year 
period (2015-2017).
Materials and Methods
The study was designed as retrospective analysis of 
data from the department of maxillofacial Surgery, 
university Clinical Center of kosovo, Prishtina, koso-
vo. The research was conducted in full accordance with 
the declaration of Helsinki on medical protocols and 
ethics. The study was approved by the Prishtina fac-
ulty of medicine Review Board. Patient consent for 
participation was not required since data were re-
trieved from our archive database, protecting privacy 
and confidentiality of patient data.
The archive contained number of cancer patients 
treated at our department from 2015 to 2017. A total 
of 1005 patients with proven carcinomas of the oral 
cavity, neck and head were selected for final analysis. 
Cancers were detected by ultrasound, x-ray, biopsy and 
clinical diagnosis. Cases were divided into groups ac-
cording to histopathologic diagnosis of cancer type. 
Statistical analysis was performed by Statistical Pack-
age of Social Sciences SPSS 21 (iBm, new york, 
uSA). Student’s t-test and Pearson’s χ2-test were per-
formed according to the type of variable. Cox regres-
sion was calculated for the evaluation of hazard ratio 
(HR) between independent and dependent variables. 
Statistical significance for all tests was set at p<0.05.
Results
Of the 1005 cases, 936 (93.1%) cases were diag-
nosed by clinical evaluation, 182 (18.1%) were con-
firmed by biopsy, 132 (13.1%) were confirmed by im-
aging (computed tomography, orthopan, craniogram), 
and 56 (5.6%) with ultrasound. The mean age of the 
study patients was 58.4±19.3 years. The majority of 
cases (n=264; 26.3%) were detected in the 7th decade of 
life (60-69 age group). Altogether 580 (57.7%) cases 
were elderly people aged ≥60 (fig. 1). furthermore, 19 
(1.9%) cases were detected in children aged ≤9 years.
in cancer patients, the most common type of oc-
cupation was retirement (n=467; 46.5%) and field 
worker (n=207; 20.6%) (Table 1). We did not establish 
the types of field work, since it could contribute to 
cancer as one of the risk factors. Sun exposure was de-
termined as the most frequent risk factor in more than 
half of cases. Treated patients had undergone surgery 
for their primary tumor. Only a minority of them re-
ceived chemotherapy or radiotherapy (alone or com-
bined). The mean time elapsed from diagnosis to treat-
ment (time-to-treat) was more than 22 months.
The most common oral cancer was basal cell carci-
noma (BCC), found in 374 (37.2%) cases, followed by 
SCC in 228 (22.7%) cases as the second most prevalent 
cancer. Other types of cancers are listed in Table 2.
The male-to-female ratio of cancer patients was 
1.7:1. According to age groups, there was no statistical 
difference between male and female patients, since 
most patients of both genders belonged to elderly 
groups. Recurrence of tumor occurred in 31 patients, 
but with no statistical gender difference. However, 50 
men had multiple-site tumors compared to 15 cases in 
women (p=0.019). The most common risk factor in 
both groups was sun exposure and contribution of 
multiple factors, mostly a combination of sun expo-
sure, alcohol and tobacco use (Table 3).
distribution of cancers by anatomic regions was 
different depending on patient gender (p<0.001) (Ta-
ble 4). The most common sites were lower lip, cheek 
region and frontal region in men, and cheek region and 
nose in women.
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in the cheek region, skin carcinoma and carcino-
mas at buccal site of the mouth and mucosa were iden-
tified. As this region was identified most commonly, 
we calculated HR for independent variables (patient 
risk factors) to predict the occurrence of cancer in the 
cheek anatomic region (Table 5). Statistically signifi-
cant risk factors for cancers in the cheek region were 
male gender, age 60-69 years, retired and field workers, 
cancer in only one region, and patients with known 
risk factors such as sun exposure, tobacco use, or their 
combination.
Discussion
The purpose of the current study was to retrospec-
tively analyze the prevalence of oral cavity, neck and 
head carcinomas, and estimate the prevalence of can-
cer subtypes at our department over a period of 3 years. 
The mean age of cancer patients in our study was 58.4 
years, which coincided with the findings from uAE 
(54.9 years)17, Thailand (59.1 years)18, iran (61.2 
years)19, malaysia (61.2 years)20, Jordan (62.5 years)21 
and Japan (65.2 years)22 but higher than data reported 
from nigeria (42.2 years)23 and india (47.8 and 49.7 
years)24,25. However, the majority of patients (n=580 
cases; 57.7%) were elderly people aged >60. As previ-
ously confirmed in many other studies19,21,26,27, male 
patients predominated with the male to female ratio of 
1.7:1 (for example, HR for cheek cancer in male pa-
tients was 1.497; p=0.003).
disparity in the prevalence of different cancer sub-
types might be attributable to difference in the distri-
bution of risk factors in each patient or geographical 
Fig. 1. Age distribution of patients with oral  
and maxillofacial tumors.
Table 1. Basic characteristics of patients with oral  
and maxillofacial tumors








































features of the region where the patient lived17,23. in 
our study, alcohol and smoking were not the dominant 
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Table 2. Prevalence and types of cancer diagnosed during 
3-year period (2015-2017)
Histology of cancer Total number of cancers (n=1005)
Adenocystic carcinoma 1 (0.1%)
Pleomorphic adenoma 7 (0.7%)
Adenoma sebaceum 2 (0.2%)
Ameloblastoma 3 (0.3%)
Angiofibroma 5 (0.5%)
Hemangioma, calcifying 1 (0.1%)
Basal cell epithelioma 1 (0.1%)
lymph node metastatic 
carcinoma 5 (0.5%)
mucoepidermoid carcinoma 2 (0.2%)
Sebaceous carcinoma 1 (0.1%)
verrucous carcinoma 6 (0.6%)
Basal cell carcinoma 284 (28.3%)
Adenoid basal cell carcinoma 53 (5.3%)
Basal cell carcinoma, cornifying 2 (0.2%)
Basal cell carcinoma cutis 3 (0.3%)
Basal cell carcinoma with 
squamous metaplasia 1 (0.1%)
Basal cell carcinoma, pigmented 2 (0.2%)
Basal cell carcinoma, adenoid 
cystic 3 (0.3%)
Basal cell carcinoma, adenoid 
keratinizing 1 (0.1%)
Basal cell carcinoma, fibrotic 3 (0.3%)
Basal cell carcinoma, 
hyperkeratotic 1 (0.1%)
Basal cell carcinoma, 
keratinizing 2 (0.2%)
Basal cell carcinoma, keratotic 2 (0.2%)
Basal cell carcinoma, superficial 17 (1.7%)
Chalazion 1 (0.1%)
Epidermal inclusion cyst 1 (0.1%)
Clear cell hidradenoma 2 (0.2%)
Squamous cell carcinoma 204 (20.3%)
Squamous cell carcinoma, 
corneal 7 (0.7%)
Squamous cell carcinoma, 
cornifying 15 (1.5%)
lymph node metastatic 
squamous cell carcinoma 1 (0.1%)
Histology of cancer Total number of cancers (n=1005)





fibrous dysplasia 5 (0.5%)
Epulis 3 (0.3%)
fibromatous epulis 3 (0.3%)
giant cell epulis 9 (0.9%)





Pyogenic granuloma 20 (2.0%)
Hemangioma 5 (0.5%)
Capillary hemangioma 9 (0.9%)
Cavernous hemangioma 4 (0.4%)
verrucous hemangioma, partial 1 (0.1%)
Sclerosing hemangioma 4 (0.4%)
Hemangioma simplex 7 (0.7%)










Actinic keratosis 9 (0.9%)
Seborrheic keratosis 33 (3.3%)
Solar keratosis 10 (1.0%)
leukoplakia 21 (2.1%)
lichen planus 3 (0.3%)
lichen simplex, chronic 1 (0.1%)
lichenoid solar keratosis 1 (0.1%)
Hodgkin lymphoma 1 (0.1%)
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risk factors. Sun exposure was detected as a risk factor 
for cancer development in more than 50% of all cases. 
kosovo as a geographic region has the mediterranean 
climate with lots of sunny days annually. in addition, 
general perception of sunbathing is that sunlight is not 
harmful, therefore people do not avoid the mid-day 
summer sun. for this reason, it would be of great inter-
est to evaluate the prevalence of skin cancer in the 
population. most of the oral, neck and head cancers in 
the present study were located in the cheek region of 
the head/face, lower lip, nose and frontal region. The 
reasons apart from risk factors were not determined. 
We demonstrated that gender, age, sun exposure and 
tobacco use could statistically contribute to cancer in 
this region. Previous studies mostly diagnosed cancer 
on the tongue17,19,22,28-30. The reasons why the tongue 
and cheek were the predilection sites for oral cancer in 




malignant melanoma, nodular 3 (0.3%)
mucoepidermoid carcinoma 1 (0.1%)
myoblastoma 1 (0.1%)
dermal nevus 1 (0.1%)
Epidermodermal nevus 5 (0.5%)
nevocellular nevus 6 (0.6%)
Pigmented nevus 14 (1.4%)
Pigmented nevus, 
epidermodermal 15 (1.5%)
Pigmented nevus, intradermal 18 (1.8%)
Sebaceous nevus 3 (0.3%)
verrucous nevus, intradermal 1 (0.1%)
Antoni A neurilemmoma 1 (0.1%)
neurofibroma 4 (0.4%)
nevocellular nevus, intradermal 1 (0.1%)
non-Hodgkin lymphoma 1 (0.1%)
Osteoma 3 (0.3%)
Papilloma 17 (1.7%)
Papilloma, inflammatory 1 (0.1%)
Papilloma, verrucous 6 (0.6%)
Polyposis 1 (0.1%)
Rhabdomyoma 1 (0.1%)
Sebaceous trichofolliculoma 1 (0.1%)
Sebaceoma 1 (0.1%)
Spindle cell nevus 1 (0.1%)
Syringoma 1 (0.1%)
Benign cystic teratoma 1 (0.1%)
Trichoepithelioma 3 (0.3%)
Trichofolliculoma 1 (0.1%)
giant cell tumor 1 (0.1%)
ulcerative eosinophilic 
granuloma (Riga-fede disease) 1 (0.1%)
verruca vulgaris 1 (0.1%)
Warthin tumor (papillary 
lymphomatous cystadenoma) 1 (0.1%)
no data 5 (0.5%)

















no data 10 6
Recurrence 18 13 0.620
Risk factors: <0.001
Sun exposure 327 188
Tobacco 40 15
Alcohol 9 2
viral infection 3 1
Chemical materials 1 3
multiple factors 158 47
no data 98 113
family history 34 23 0.550
multi-site 50 15 0.019
 
Table 2. Continued
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those studies are that the carcinogens mixing with sa-
liva in the oral cavity have a tendency to pool at the 
bot tom of the mouth and these sites are covered by 
thin and non-keratinized mucosa, thus providing less 
protection against the carcinogen31. On the other 
hand, Chidzonga32 reports on gingiva as the most 
common site of oral cancer, followed by the tongue. in 
our study, tongue and gingiva cancer together account-
ed for only 3.3% of all cancers. However, Howell et 
al.33 report that the most common site of oral cancer in 
their study was the lip, followed by the tongue, which 
coincided with our findings regarding lip cancer. The 
explanation for the high incidence of lip cancer was 
sun exposure and ultraviolet light overexposure, which 
also coincided with our results. Aus tralia, where the 
study was performed, also is a sunny country and its 
residents, mostly immigrants from Europe, have fair 
skin complexion and thus higher probability of skin 
damage. A study from india determined cancer of 
buccal muco sa as the second most common in their 
population, attributed to tobacco chewing25. As a con-
sequence, alveolar mucosa, gingiva and buccal mucosa 
are constantly in contact with the carcinogens for a 
long period of time. in our analysis, tobacco was iden-
tified as a risk factor in 55 patients.
Regarding cancer subtypes in the present study, 
BCC accounted for 37.2% and SCC for 22.7% of all 
oral cancers. These figures are much lower than those 
reported in several previous studies, which found SCC 
to account for 84.4% to 90.0% of all oral can-
cers2,19-20,29,33. However, lower figures from 63.0% to 
73.1% have also been reported17,23,30,32, but not under 
20% to 25%. Head and neck SCC has been established 
worldwide as one of the most frequent cancers. its in-
cidence is 2.5% and it annually contributes to 1.9% of 
all deaths from cancer. The majority of oral cancers are 
Table 4. Distribution of cancers according to anatomic region and patient gender





lower lip 167 16.6% 139 28
upper lip 28 2.9% 11 17
nose 143 14.2% 78 65
frontal region 114 11.3% 85 29
Cheek region 221 22.0% 115 106
Region covered with hair 92 9.2% 66 26
Parotid gland 6 0.6% 1 5
Palate 5 0.5% 4 1
medial canthus of eye 10 1.0% 6 4
lateral canthus of eye 8 0.8% 4 4
upper eyelid 9 0.9% 5 4
lower eyelid 9 0.9% 6 3
neck region 40 4.0% 23 16
Oral mucosa 10 1.0% 4 6
Tongue 17 1.7% 10 7
gingiva 16 1.6% 3 13
floor of the mouth 0 0 0 0
Ear 27 2.7% 22 5
Other salivary glands 1 0.1% 0 1
upper jaw 18 1.8% 13 5
lower jaw 9 0.9% 7 2
frontal bone 1 0.1% 0 1
no data 54 5.3% 34 81
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Table 5. Predictive values of risk factors with calculated HR with 95% CI for cancer in cheek 
region
B HR 95% Ci p-value
gender 0.404 1.497 1.146 1.965 0.003
Age group (years):
0-9 Reference
10-19 -1.078 0.340 0,062 1.858 0.213
20-29 -0.932 0.394 0,098 1.577 0.188
30-39 -0.443 0.642 0,213 1.940 0.433
40-49 -0.442 0.643 0,209 1.976 0.440
50-59 -0.013 0.987 0,342 2.846 0.980
60-69 -1.232 0.292 0,099 0.859 0.025
70-79 -0.425 0.654 0,237 1.804 0.412
80-89 -0.425 0.654 0,236 1.811 0.414
90-99 -0.210 0.810 0,28 2.343 0.698
Occupation:
Worker Reference
Housewife 0.543 1.722 0,951 3.115 0.073
Retiree 0.798 2.220 1,283 3.844 0.004
Pupil 0.575 1.778 1,116 2.832 0.015
Student 0.324 1.383 0,473 4.042 0.553
Child <6 years 0.997 2.710 1,240 5.923 0.012
field worker 1.083 2.953 1,187 7.344 0.020
Birthplace -0.162 0.850 0.642 1.127 0.259
Recurrence -0.540 0.583 0.211 1.609 0.297
multi-site -0.912 0.402 0.198 0.814 0.011
Risk factors:
Sun exposure Reference
Tobacco 0.539 1.714 1,118 2.627 0.013
Alcohol 0.141 1.151 0,472 2.810 0.757
various chemical 
materials 1.051 2.861 0,387 21.169 0.303
multiple 0.808 2.243 1,379 3.648 0.001
family history -0.132 0.876 0.524 1.464 0.614
*Hazard ratios (HR) were calculated with Cox regression, where presence of cancer was dependent variable; B 
value was determined as correlation coefficient between independent and dependent variable; 95% Ci = 95% 
confidence interval.
histologically SCC34. Head and neck SCC is normally 
detected in elderly people, but an increasing incidence 
among younger patients aged <45 has been observed 
in recent years. However, cancer in younger people is 
known to be a different clinical entity with different 
etiologic factors and pathogenesis. There is also a dis-
tinctive discrepancy in the estimated proportion of 
oral cancers in younger patients among different re-
gions, e.g., north America (5.5%), Africa (17.2%) and 
middle East (14.5%). Therefore, we need to conduct 
more population-based incidence studies also in non-
Western regions to obtain a more accurate proportion 
of incidence in younger population, and also to iden-
tify the etiologic risk factors for the disease35. interest-
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ingly, in previous studies on the epithelial tumor cate-
gory, SCC was the most common tumor and the most 
common oral cancer17,19-27,29,32,33, while mucoepi-
dermoid carcinoma was most prevalent in the salivary 
gland tumor category17,20,27, whereas in our study it ac-
counted for only 0.1% of all cancers. The prevalence 
data do differ among countries, however, mostly be-
tween the Western countries and third-world coun-
tries.
Basal cell carcinoma was proved to be the most fre-
quent subtype in our study, and is also the most com-
mon malignancy in Caucasians36-40, with over two mil-
lion cases diagnosed in the uSA each year39. it is be-
lieved that BCC originates from the basal layer of the 
epidermis, the interfollicular epidermis and the hair 
follicle41. Approximately 95% of individuals are diag-
nosed with BCC between the age of 40 and 79 years. 
The incidence is approximately 30% higher in men 
than in women. The risk factors include fair skin pig-
mentation, sun radiation (ultraviolet and/or ionizing), 
exposure to arsenic or polycyclic aromatic hydrocar-
bons, immunosuppression, scars, and certain genetic 
syndromes41. BCC frequently has benign evaluation 
despite the high rate of local recurrence. About 80% of 
BCCs are located in the head or neck. Several lines of 
evidence suggest that the worldwide incidence of BCC 
is increasing42. metastatic BCC is extremely rare, with 
the incidence rates up to 0.5%. it is defined as a pri-
mary cutaneous BCC that spreads to distant sites as 
histologically similar metastatic deposits of BCC43.
Patients with oral and maxillofacial tumors have a 
high risk of local recurrence, but the risk of distant re-
currence is low4. Recurrence was found in only 31 
(3.1%) of all included patients, with no data on the 
region cancer recurrence. for instance, montero and 
Patel4 report that the possibility of a second head and 
neck cancer is only 4%-7% per year because compre-
hensive clinical examinations and already a high suspi-
cion in such cancer patients are the main reasons for 
early diagnosis and early detection.
The main strength of this study was its design. Al-
though it was retrospective analysis of data, it was 
based on the method of population-based data, which 
were collected in a precise and rigorous manner from 
medical files in order to know all the characteristics of 
the cancer patients included in final analysis. Thus, de-
spite some absent data from medical records, missing 
values were minor. The inclusion of patients from the 
cancer archive allowed us to overcome recruitment 
bias and gave us information on the totality of cancer 
cases in the given geographic area of kosovo. The main 
limit of our study was the limited study area, since data 
were only obtained from one archive instead of multi-
ple centres, and consequently a relatively small number 
of patients were included in the 3-year analysis. How-
ever, this study required an extended, standardized, 
dedicated registration, since in kosovo we do not run 
cancer registries for collection and management of 
data from patients with oral, neck or head cancers. So, 
this was the first study of this kind conducted in koso-
vo. Another limitation was design of the study, which 
did not assess all patient data and information. Time 
elapsed between diagnosis and treatment (time-to-
treat) was investigated and showed considerable delay. 
it was generally long (median approximately 9 months, 
mean 22 months), however, we often could not iden-
tify the reason for this. despite recommendations for 
early detection, cancers are still diagnosed rather late 
in kosovo.
Conclusions
Oral cancers significantly contribute to patient 
mortality and morbidity, especially when detected late 
in the course of disease. This study highlighted data on 
gender distribution of cancer and provided informa-
tion on anatomic locations where oral can cers were 
frequently detected. Considering prevalence data, cli-
nicians should pay attention to the cheek region, mu-
cosa and lip for early detection of cancers, since these 
regions were most common in our study. This study 
also showed differences between age groups, where el-
derly had a much higher probability of oral cancers 
compared to younger patients.
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Sažetak
AnAliZA TROgOdiŠnJE uČESTAlOSTi TumORA uSnE ŠuPlJinE, vRATA i glAvE  
– RETROSPEkTivnO iSTRAŽivAnJE u JEdnOm CEnTRu
S. Rusinovci, X. Aliu, T. Jukić, D. Štubljar i N. Haliti
Cilj ovoga istraživanja bio je analizirati učestalost tumora usne šupljine, vrata i glave u našoj klinici tijekom trogodišnjeg 
razdoblja. Retrospektivnom analizom obuhvaćeni su arhivski podaci za bolesnike s karcinomom liječene na našoj klinici od 
2015. do 2017. godine. Za konačnu analizu odabrano je ukupno 1005 bolesnika s dokazanim karcinomom. karcinomi su 
otkriveni ultrazvukom, rendgenskim snimanjem, biopsijom i kliničkom dijagnostikom. Srednja dob bolesnika bila je 
58,4±19,3 godine. većina slučajeva (n=264; 26,3%) otkrivena je u sedmom desetljeću života. najčešći tipovi karcinoma bili 
su bazocelularni karcinom utvrđen u 374 (37,2%) i planocelularni karcinom u 228 (22,7%) slučajeva. Omjer muških i ženskih 
bolesnika bio je 1,7:1. među spolovima nije bilo statistički značajne razlike u dobi. Ponovna pojava tumora zabilježena je u 
31 bolesnika. izlaganje suncu bio je najčešći čimbenik rizika u objema skupinama. najčešća mjesta nastanka tumora bili su 
donja usnica, obrazi i frontalna regija kod muškaraca te područje obraza i nos kod žena (p<0,001). vjerojatnost razvoja kar-
cinoma bila je veća kod muškaraca. Studija je pokazala razlike među dobnim skupinama, tj. vjerojatnost razvoja karcinoma 
bila je znatno veća kod starijih  bolesnika u usporedbi s mlađim bolesnicima.
ključne riječi: Trogodišnji podaci; Učestalost; Karcinomi usne šupljine; Čimbenici rizika; Retrospektivna analiza
